Invasive candidiasis remains a leading cause of morbidity and mortality in various categories of patients at risk.

An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old / Bassetti, Matteo; Giacobbe, Daniele Roberto; Vena, Antonio; Esposito, Susanna. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - (2022). [10.1080/14656566.2022.2147824]

An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old

Esposito, Susanna
2022-01-01

Abstract

Invasive candidiasis remains a leading cause of morbidity and mortality in various categories of patients at risk.
2022
An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old / Bassetti, Matteo; Giacobbe, Daniele Roberto; Vena, Antonio; Esposito, Susanna. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - (2022). [10.1080/14656566.2022.2147824]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2933060
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact